Cover Image
Market Research Report - 242604

Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015

Published by GlobalData
Published Content info 292 Pages
Price
Back to Top
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015
Published: December 16, 2015 Content info: 292 Pages
Description

GlobalData's clinical trial report, "Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Irritable Bowel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Irritable Bowel Syndrome Therapeutics Clinical Trials 29
  • Prominent Drugs 31
  • Latest Clinical Trials News on Irritable Bowel Syndrome 32
  • Nov 30, 2015: Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan 32
  • Nov 19, 2015: Synthetic Biologics to Host Microbiome Clinical Program Seminar in New York City 32
  • Nov 02, 2015: Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation 33
  • Oct 20, 2015: Synthetic Biologics' Novel Irritable Bowel Syndrome with Constipation Program Featured in American College of Gastroenterology Poster 33
  • Oct 19, 2015: Allergan to Present New Data for VIBERZI (eluxadoline) at the American College of Gastroenterology 2015 Annual Scientific Meeting 34
  • Oct 14, 2015: RedHill Biopharma Provides Update on BEKINDA Ongoing Phase III Study for Gastroenteritis and Announces Planned Phase II Study for IBS-D 35
  • Oct 13, 2015: Ironwood Reports Positive Top-Line Results from Phase III Trial of 72 mcg Linaclotide in Adults with Chronic Idiopathic Constipation 36
  • Oct 08, 2015: Synthetic Biologics Initiates Second SYN-010 Phase 2 Clinical Trial Intended to Treat Irritable Bowel Syndrome with Constipation (IBS-C) 37
  • Oct 08, 2015: Ardelyx to Present Phase 2 Data for Tenapanor in IBS-C Patients at the 2015 American College of Gastroenterology Annual Meeting 37
  • Clinical Trial Profile Snapshots 39

Appendix 289

  • Abbreviations 289
  • Definitions 289
  • Research Methodology 290
  • Secondary Research 290
  • About GlobalData 291
  • Contact Us 291
  • Disclaimer 291
  • Source 292

List of Tables

List of Tables

  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 6
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 16
  • Irritable Bowel Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
  • Irritable Bowel Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 19
  • Irritable Bowel Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
  • Irritable Bowel Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 22
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

List of Figures

List of Figures

  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
  • Irritable Bowel Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
  • Irritable Bowel Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 19
  • Irritable Bowel Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
  • Irritable Bowel Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23
  • Irritable Bowel Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
  • Irritable Bowel Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
  • Irritable Bowel Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
  • GlobalData Methodology 290
Back to Top